peptidio ghk cu GHK-Cu Injectable 89030-95-5 GHK-Cu Gly-His-Lys-Cu Copper Tripeptide-1;

A 250mcg dose thus requires 0.1ml (10 units on a standard insulin syringe)

PMID 8298641

doi: 10.1007/s00011-012-0512-0

Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing